Markets:

Overview

News

Currencies

International

Treasuries

Adicet Bio, Inc. - Common Stock (NQ:ACET)

8.900 +0.460 (+5.45%)

Streaming Delayed Price Updated: 11:50 AM EST, Jan 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Adicet Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Adicet Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress

March 15, 2023

From Adicet Bio, Inc.

Via Business Wire

7 Biotech Stocks That Could Be the Next Big Thing ↗

March 15, 2023

Although speculation might be a tough call at this juncture, these biotech stocks and their underlying science might be compelling enough.

Via InvestorPlace

Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit

March 09, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

February 28, 2023

From Adicet Bio, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Wednesday ↗

February 15, 2023

On Wednesday, 35 stocks hit new 52-week lows.

Via Benzinga

Adicet Bio to Participate in a Fireside Chat at the 2023 Guggenheim Oncology Conference

February 01, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

January 31, 2023

From Adicet Bio, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

January 10, 2023

Tuesday's session saw 16 companies set new 52-week lows.

Via Benzinga

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

December 30, 2022

From Adicet Bio, Inc.

Via Business Wire

Peering Into Adicet Bio's Recent Short Interest ↗

December 13, 2022

Adicet Bio's (NASDAQ:ACET) short percent of float has risen 29.62% since its last report. The company recently reported that it has 4.02 million shares sold short, which is 12.56% of all regular shares...

Via Benzinga

Dow Surges Over 250 Points; Weber Shares Spike Higher ↗

December 12, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 250 points on Monday

Via Benzinga

Stocks Hold Gains Ahead Of Tuesday's Economic Flurry ↗

December 12, 2022

The major indexes are continuing their move higher this afternoon, as investors await tomorrow's release of November's consumer price index (CPI) data.

Via Talk Markets

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 12, 2022

Via Benzinga

Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

December 12, 2022

Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.

Via Benzinga

Crude Oil Rises Sharply; Adicet Bio Shares Plunge ↗

December 12, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 250 points on Monday

Via Benzinga

RH, HUYA, Bilibili And Some Other Big Stocks Moving Lower On Monday ↗

December 12, 2022

U.S. stocks traded higher, with the Dow Jones jumping more than 200 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Adicet Bio Shares Fall After Underwhelming Data From Non-Hodgkin's Lymphoma Study ↗

December 12, 2022

Via Benzinga

US Stocks Higher; Dow Rises Over 100 Points ↗

December 12, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Monday

Via Benzinga

Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket ↗

December 12, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 12, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

December 12, 2022

We're starting off the week with a look at the biggest pre-market stock movers traders need to know about for Monday morning!

Via InvestorPlace

Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)

December 10, 2022

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio to Host Investor Webcast to Discuss Updated Clinical Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)

December 02, 2022

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

November 30, 2022

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio to Present at the Virtual JMP Securities Hematology and Oncology Summit

November 30, 2022

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio Appoints Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory Officer

November 29, 2022

From Adicet Bio, Inc.

Via Business Wire

Gamma Delta T Cell Therapy Market Could Reach $4 Billion As Biotechs Race To Get Breakthrough Cancer Treatment Approved ↗

November 22, 2022

This year, the World Health Organization (WHO) announced that cancer has become the leading cause of death worldwide, with the latest data showing that nearly 10 million deaths in 2020 were the result...

Via Benzinga

Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday ↗

November 17, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.

Via Benzinga

Target, Holley, Ferroglobe And Other Big Losers From Wednesday ↗

November 17, 2022

U.S. stocks closed mostly lower on Wednesday, with the Nasdaq Composite dropping around 175 points. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Adicet Reports Third Quarter 2022 Financial Results and Provides Business Updates

November 08, 2022

From Adicet Bio, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.